COMPARATIVE-STUDY OF THE EFFICACY OF KETOPROFEN ACCORDING TO THE ROUTE OF ADMINISTRATION (INTRAMUSCULAR OR ORAL) - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:0
|
作者
DOUGADOS, M
LISTRAT, V
DUCHESNE, L
AMOR, B
机构
来源
REVUE DU RHUMATISME | 1992年 / 59卷 / 11期
关键词
KETOPROFEN; RHEUMATOID ARTHRITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence of the analgesic effects of nonsteroidal antiinflammatory drugs in human diseases is easy to collect. However, demonstration of differences in the activity of NSAIDs according to the route of administration is considerably more difficult. Forty patients with rheumatoid arthritis were given either one intramuscular injection of 100 mg ketoprofen with two placebo capsules or one intramuscular injection of placebo with two 50 mg ketoprofen capsules. Analysis of changes in pain severity over the six-hour study period failed to disclose any statistically significant differences between the two groups. However, time to peak effectiveness (Tmax) was significantly shorter with the intramuscular route (194 +/- 118 minutes) than with the oral route (276 +/- 111 minutes) (p = 0.029). Although intramuscular NSAID therapy is rarely warranted in RA patients, these findings suggest that RA may serve as a clinical model for evaluating the effectiveness of a NSAID according to the route of administration.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 50 条
  • [41] A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
    Wan, Yingying
    Yang, Jiaxi
    Ma, Tianyue
    Wang, Wenqian
    Wang, Haonan
    Sun, Wenting
    Ye, Wanting
    Yang, Lin
    Ren, Jianxun
    Kou, Qiuai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] DOUBLE-BLIND RADIOLOGICAL ASSESSMENT OF CONTINUOUS ORAL PAMIDRONIC ACID IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    MACCAGNO, A
    DIGIORGIO, E
    ROLDAN, EJA
    CABALLERO, LE
    LLORET, AP
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (04) : 211 - 214
  • [43] Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis
    Kawai, Shinichi
    Hashimoto, Hiroshi
    Kondo, Hirobumi
    Murayama, Takashi
    Kiuchi, Takahiro
    Abe, Toru
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2153 - 2161
  • [44] A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis
    Hilliquin, P
    Chermat-Izard, V
    Menkes, CJ
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (08) : 1502 - 1507
  • [45] Acupuncture in the treatment of rheumatoid arthritis: A double-blind controlled pilot study
    Tam L.-S.
    Leung P.-C.
    Li T.K.
    Zhang L.
    Li E.K.
    BMC Complementary and Alternative Medicine, 7 (1):
  • [46] Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study
    Genovese, Mark C.
    Spindler, Alberto
    Sagawa, Akira
    Park, Won
    Dudek, Anna
    Kivitz, Alan
    Chao, Jeannie
    Chan, Lai Shan Melanie
    Witcher, Jennifer
    Barchuk, William
    Nirula, Ajay
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 969 - 976
  • [47] Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid Arthritis
    Chen, Der-Yuan
    Chou, Show-Jan
    Hsieh, Tsu-Yi
    Chen, Yi-Hsing
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lan, Joung-Liang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (04) : 310 - 319
  • [48] Monoarticular corticosteroid injection versus systemic administration in the treatment of rheumatoid arthritis patients: a randomized double-blind controlled study
    Konai, M. S.
    Vilar Furtado, R. N.
    dos Santos, M. F.
    Natour, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 214 - 221
  • [49] PRTX-100 and Methotrexate in Patients With Active Rheumatoid Arthritis: A Phase Ib Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study
    Bernton, Edward
    Gannon, William
    Kramer, William
    Kranz, Eduard
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 477 - 486
  • [50] PATIENTS WITH RHEUMATOID-ARTHRITIS BENEFIT FROM EARLY 2ND LINE THERAPY - 5-YEAR FOLLOW-UP OF A PROSPECTIVE DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    EGSMOSE, C
    LUND, B
    BORG, G
    PETTERSSON, H
    BERG, E
    BRODIN, U
    TRANG, L
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (12) : 2208 - 2213